Industry veteran to enhance “system of winning” for revenue cycle technology leader
ATLANTA, CHICAGO, LOUISVILLE – June 28, 2018 — Waystar™, the combination of Navicure® and ZirMed® revenue cycle technologies, today announced Steve Oreskovich has joined the company as Chief Financial Officer (CFO). Steve will assume CFO responsibilities from Jim Lacy, who continues in his role as Waystar’s Counsel and will lead corporate strategy as Chief Strategy Officer focused on partnerships and mergers and acquisitions. With more than 20 years of experience driving revenue and structural improvements with leading healthcare and technology companies, Steve joins Waystar at a time of strong revenue and profitability growth following the recent merger of Navicure and ZirMed.
Steve joins Waystar from Merge Healthcare, which IBM acquired in October 2015, where he served as Chief Financial Officer and Treasurer of the public company. During his tenure as CFO of Merge, now rebranded as Watson Health Imaging, he partnered with the CEO to increase revenue by more than 300 percent through numerous acquisitions and organic product expansion. Prior to Merge, Steve held progressive financial roles within companies such as Truis, Inc. and PricewaterhouseCoopers LLP. He holds a B.S. in accounting from Marquette University and an active C.P.A. license in Wisconsin.
“I’m thrilled to be joining Waystar at this exciting time,” said Mr. Oreskovich. “Waystar is uniquely positioned to dramatically improve how every healthcare organization in the U.S. manages its revenue cycle. Waystar’s next-generation technology combined with industry-leading client service enable it to simplify and unify revenue cycle management in a way that has never been done. The best part is that Waystar is just getting started, even as one of the largest companies in the industry. I’m looking forward to helping lead this successful company to the next level.” Jim Lacy added, “I have enjoyed getting to know Steve throughout our rigorous search process and am excited to collaborate with him on future growth opportunities with Waystar.”
“Steve is an exceptional addition to Waystar’s already strong leadership team,” said Matt Hawkins, Waystar’s CEO. “There’s an incredible energy to our organization as we concurrently integrate the two leading providers of revenue cycle technology and grow the combined company. Steve will focus on enhancing our ‘system of winning’ as we accelerate both organic and inorganic growth. He will partner closely with Jim Lacy, who will now have more time to focus on corporate development and leverage his unique combination of strategic, legal and financial skills.”
Waystar is the combination of Navicure and ZirMed, the two top-rated providers of revenue cycle technologies. Waystar simplifies and unifies the healthcare revenue cycle with innovative technology that allows clients to collect more with less cost and less stress, so they can focus on their goals, patients and communities. Navicure and ZirMed are recognized as industry leaders, collectively scoring Best in KLAS® claims clearinghouse every year since 2010, including 2018, and earning multiple #1 rankings in both medical claims processing and patient payment solutions from Black Book™ surveys since 2012. ZirMed has received the “Peer Reviewed by HFMA” designation through the Healthcare Financial Management Association (HFMA). The combined company supports more than 400,000 providers, hospitals, health systems and ambulatory services organizations and partners with the leading EHR and practice management solution providers. For more information, visit www.waystar.com, www.navicure.com, and www.zirmed.com or follow @Waystar_RCT, @Navicure, and @ZirMed on Twitter.